Marta C Monteiro | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Prof. Dr. Marta C Monteiro | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Professora Associada at Universidade Federal do Pará, Brazil

Dr. Marta Chagas Monteiro is a distinguished biomedical researcher specializing in microbiology, immunology, and pharmacology. She holds a CNPq 1D Productivity Scholarship and serves as a professor and research coordinator at the Federal University of Pará (UFPA), Brazil. With over two decades of experience, she has made significant contributions to understanding infectious diseases, immune responses, and drug development. Her collaborations span international institutions, including the University of São Paulo, Aston University, and the University of Shanghai. As a prolific researcher, she has authored over 100 high-impact publications and serves on the editorial boards of leading scientific journals. Dr. Monteiro is also an active mentor, shaping future scientists through postgraduate programs. Her expertise in oxidative stress, biomarkers, and xenobiotic toxicity has positioned her as a leading figure in biomedical research, earning her recognition from national and international funding agencies.

Professional Profile

Education

Dr. Monteiro earned her Ph.D. in Basic and Applied Immunology from the University of São Paulo in 2004, focusing on immune responses and cellular migration in infectious diseases. Prior to that, she completed her Master’s degree in the same field at USP in 2000, with research centered on parasitology and pharmacology. Her academic foundation was laid at the Federal University of Pará, where she obtained a bachelor’s degree in Medical Biology in 1997. Over the years, she has pursued numerous specialized training courses in pharmacology, immunology, and biomedicine, including programs on oxidative stress, epigenetics, and experimental pharmacology. Her continuous education reflects a commitment to interdisciplinary research, integrating immunopharmacology, microbiology, and biotechnology into her work. This extensive academic background has enabled her to make significant contributions to scientific advancements, particularly in the study of immune responses, biomarkers, and the pharmacological effects of drugs on infectious and neurodegenerative diseases.

Professional Experience

Dr. Monteiro is a professor and coordinator at the Faculty of Pharmacy at UFPA, where she leads the Laboratory of Oxidative Stress and Clinical Immunology. She is actively involved in postgraduate programs in pharmaceutical sciences, neuroscience, and pharmacology. Beyond academia, she serves as an expert evaluator for major funding organizations, including CNPq, SUS, and INEP. Her work also extends to international collaborations, with ongoing projects in partnership with institutions in Brazil, the UK, and China. Additionally, she is a consultant for over 15 research development agencies and a reviewer for more than 90 scientific journals. As part of her professional engagements, she has contributed to the development of new pharmacological treatments, diagnostic tools, and innovative technologies in immunology. Her leadership in academia and research has significantly impacted biomedical advancements, particularly in the areas of infectious disease management and pharmacological interventions.

Research Interests

Dr. Monteiro’s research focuses on microbiology, clinical immunology, and pharmacology, with a particular emphasis on biomarkers and immune responses in infectious diseases. She investigates the pharmacological activities of drugs and natural products, as well as their toxicological effects on human health. Her work extends to studying oxidative stress, inflammation, and xenobiotic-mediated toxicity, providing insights into the development of new therapeutic strategies. Additionally, she explores neurodegenerative, autoimmune, and parasitic diseases, including malaria, tuberculosis, leishmaniasis, and sepsis. Through her extensive research, she has contributed to advancements in immunopharmacology, helping to identify novel drug targets and therapeutic interventions. Her multidisciplinary approach, combining molecular biology, pharmacology, and biotechnology, has led to breakthroughs in disease diagnostics and treatment methodologies, further solidifying her reputation as a leading expert in biomedical sciences.

Awards and Honors

Dr. Monteiro has received numerous accolades in recognition of her contributions to biomedical research. She is a recipient of the prestigious CNPq 1D Productivity Scholarship, which highlights her excellence in scientific investigation. Her research has been funded by national and international agencies, reflecting the high impact of her work. She has also been recognized for her role as an editor and reviewer for top-tier journals, including Frontiers in Immunology and Oxidative Medicine and Cellular Longevity. Additionally, she has contributed to the scientific community as a consultant and evaluator for research projects funded by leading organizations. Her patents and published innovations in immunopharmacology and microbiology have further established her as a respected figure in the field. Through her dedication to research, teaching, and mentorship, she has made a lasting impact on the scientific landscape, earning widespread recognition for her contributions to global health and biomedical advancements.

Conclusion

Dr. Marta Chagas Monteiro is highly qualified for the Best Researcher Award due to her extensive contributions, leadership in microbiology and immunology, international collaborations, and significant research impact. Strengthening her translational research and public engagement could further enhance her profile, but overall, she is a strong candidate.

Publications Top Notes

  1. Monteiro, M.C., Quadros Gomes, B.A., Dos Santos, S.M., Gato, L.D.S., Coleman, M.D. (2025)

    • Alpha-Lipoic Acid Reduces Neuroinflammation and Oxidative Stress Induced by Dapsone in an Animal Model.

    • Journal: Nutrients

    • Citations: 0

  2. Monteiro, M.C., de Farias, E.C.F., Pavão Júnior, M.J.C., de Sales, S.C.D., Terreri, M.T.R.A. (2024)

    • Factors associated with mortality in children with critical COVID-19 and multisystem inflammatory syndrome in a resource-poor setting.

    • Journal: Scientific Reports

    • Citations: 2

  3. Monteiro, M.C. (co-author), Dos Santos, É.R.Q., Pantoja, L.V.P.D.S., Farias, S.V., Maia, J.G.S., Maia, C.S. (2024)

    • Linalool-rich rosewood essential oil (Aniba rosaeodora Ducke) mitigates emotional and neurochemical impairments induced by ethanol binge-like exposure during adolescence in female rats.

    • Journal: Biomedicine and Pharmacotherapy

    • Citations: 0

  4. Monteiro, M.C., Navegantes-Lima, K.C., Gaspar, S.L.D.F., De, A.L., Sovrani, V. (2024)

    • Lipid Fraction from Agaricus brasiliensis as a Potential Therapeutic Agent for Lethal Sepsis in Mice.

    • Journal: Antioxidants

    • Citations: 0

  5. Monteiro, M.C. (co-author), de Farias, E.C.F., Nascimento, L.M.P.P., Pavão Júnior, M.J.C., Clemente, G., Terreri, M.T.R.A. (2024)

    • Plasma IL-17A is increased in patients with critical MIS-C and associated with in-hospital mortality.

    • Journal: Frontiers in Immunology

    • Citations: 0

  6. Monteiro, M.C., Matos-Sousa, J.M., Chemelo, V.S., Frazão, D.R., Lima, R.R. (2024)

    • Is there any association between the presence of biomarkers and apical periodontitis? A systematic review.

    • Journal: [No source information available]

    • Citations: 3

  7. Monteiro, M.C., Valois, F.P., Bezerra, K.C.A., da Costa Assunção, F.P., Machado, N.T. (2024)

    • Improving the Antioxidant Activity, Yield, and Hydrocarbon Content of Bio-Oil from the Pyrolysis of Açaí Seeds by Chemical Activation: Effect of Temperature and Molarity.

    • Journal: Catalysts

    • Citations: 1

  8. Monteiro, M.C., Meneses, C.C.F., de Sousa, P.R.M., Lima, K.C.N., Lameira, J. (2023)

    • Caffeic Acid-Zinc Basic Salt/Chitosan Nanohybrid Possesses Controlled Release Properties and Exhibits In Vivo Anti-Inflammatory Activities.

    • Journal: Molecules

    • Citations: 3

  9. Monteiro, M.C. (co-author), Camara, F.M.S., da Conceição, B.C., Cardoso, E.K.S., Maia, C.S., Fontes-Júnior, E.A. (2023)

    • Margaritaria nobilis L.f. (Phyllanthaceae) Ethanolic Extract: Low Acute Oral Toxicity and Antinociceptive Activity.

    • Journal: Pharmaceuticals

    • Citations: 1

  10. Monteiro, M.C. (co-author), Dorneles, G.P., Teixeira, P.C., Peres, A.L., Wendland, E.M., Romão, P.R.T. (2023)

  • Endotoxin tolerance and low activation of TLR-4/NF-κB axis in monocytes of COVID-19 patients.

  • Journal: Journal of Molecular Medicine

  • Citations: 8

 

Mrs. fangyan He | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Mrs. fangyan He | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Senior Experimentalist at Yunnan University of Traditional Chinese Medicine, China

He Fangyan is a distinguished researcher specializing in the pharmacodynamics and pharmacokinetics of traditional Chinese medicine. Currently serving as a Senior Experimentalist at Yunnan University of Traditional Chinese Medicine, she has led multiple high-impact studies focusing on ischemic stroke mechanisms and brain pharmacokinetics. With a commitment to advancing neuropharmacology, she has secured prestigious research grants, contributed to key scientific advancements, and developed innovative methodologies in cerebral ischemia treatment. Her expertise extends to drug metabolism, blood-brain barrier protection, and targeted drug delivery, making her a prominent figure in the field. Through her patents, publications, and ongoing research, she continues to bridge the gap between traditional Chinese medicine and modern pharmacological science.

Professional Profile

Education

He Fangyan holds an advanced degree in pharmacology and traditional Chinese medicine research, equipping her with interdisciplinary expertise in both experimental and clinical pharmacokinetics. She has undergone rigorous training in drug absorption, metabolism, and pharmacodynamics, particularly focusing on ischemic stroke therapies. Her academic background includes specialized studies in cerebral ischemia-reperfusion injury and neuroprotection, which laid the foundation for her innovative research contributions. She has further enhanced her knowledge through postgraduate research projects, technical training in pharmacological analysis, and collaborations with leading scientists in neurological drug development. Her education has provided her with a strong analytical and methodological foundation, enabling her to conduct cutting-edge research in traditional Chinese medicine’s role in stroke management.

Professional Experience

With extensive experience in experimental pharmacology and neuroscience, He Fangyan has held a senior research position at Yunnan University of Traditional Chinese Medicine, leading multiple research projects funded by national and provincial grants. She has played a pivotal role in advancing traditional Chinese medicine applications for stroke treatment, particularly through the study of Gastrodia’s neuroprotective effects. Over the years, she has worked on high-impact studies integrating brain microdialysis, PK/PD modeling, and oxidative stress mechanisms. In addition to academic research, she has contributed to methodology development in neuropharmacology, ensuring precise drug targeting and evaluation of traditional medicine compounds. Her professional contributions also extend to mentoring young researchers and fostering interdisciplinary collaborations, strengthening the field of pharmacokinetics and neuroprotection.

Research Interests

He Fangyan’s primary research interests revolve around cerebral ischemia, blood-brain barrier protection, and pharmacokinetics of traditional Chinese medicine compounds. She is particularly focused on understanding the mechanisms of ischemic stroke and the therapeutic potential of Gastrodia-derived compounds in treating oxidative stress-induced brain damage. Her studies employ microdialysis techniques, drug metabolism analysis, and neuroprotective compound development, making significant contributions to stroke research. She is also deeply invested in the translation of traditional Chinese medicine principles into modern pharmacological applications, aiming to bridge ancient remedies with contemporary scientific methodologies. Additionally, she explores novel drug delivery systems and prodrug mechanisms, ensuring targeted treatment with minimal side effects for cerebrovascular diseases.

Awards and Honors

He Fangyan has been recognized for her outstanding contributions to traditional Chinese medicine research and neuropharmacology. She has received funding from prestigious institutions such as the National Natural Science Foundation of China and the Yunnan Science and Technology Department, reflecting the significance of her work. Her patented innovations in cerebral ischemia treatment have earned acclaim, contributing to advancements in stroke therapy. She has also published extensively in SCI-indexed journals, further solidifying her academic reputation. As a key figure in pharmacokinetics and stroke research, she has been invited to speak at academic conferences and collaborate on national research initiatives. Her dedication to scientific progress and innovation continues to garner recognition, positioning her as a leading researcher in the field of traditional Chinese medicine and neuroscience.

Conclusion

He Fangyan is a strong candidate for the Best Researcher Award due to extensive contributions to pharmacokinetics and stroke research, significant grant funding, patents, and high-impact journal publications. Strengthening industry ties, international collaborations, and academic outreach could further solidify eligibility for top-tier research awards.

Publications Top Noted

  • He, F., Feng, J., Sun, H., Xu, Y., Yan, H., Song, X., Wang, Y., Li, X., & Lin, Q. (2024). Protective Effect of Protocatechuic Aldehyde on Cerebral Ischemia/Reperfusion Injury in Rats through Blood–Brain Barrier Protection. Bulletin of Experimental Biology and Medicine. https://doi.org/10.1007/s10517-024-06264-z

  • He, F., Xu, C., Feng, J., Sun, H., Yan, M., Yang, Q., Zhou, X., Yang, J., & Lin, Q. (2024). Pharmacokinetics of 4-Hydroxybenzaldehyde in Normal and Cerebral Ischemia–Reperfusion Injury Rats Based on Microdialysis Technique. European Journal of Drug Metabolism and Pharmacokinetics. https://doi.org/10.1007/s13318-023-00863-3

  • He, F., Ma, C., Feng, J., Li, X., Xia, S., Lin, Q., Dai, R., & He, F. (2021). Angiogenesis effects of 4-methoxy benzyl alcohol on cerebral ischemia-reperfusion injury via regulation of VEGF-Ang/Tie2 balance. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2021-0118

  • He, F., Dai, R., Zhou, X., Li, X., Song, X., Yan, H., Meng, Q., Yang, C., & Lin, Q. (2019). Protective effect of 4-Methoxy benzyl alcohol on the neurovascular unit after cerebral ischemia reperfusion injury. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2019.109260

  • He, F., Duan, X., Dai, R., Li, Y., & Lin, Q. (2017). Protective Effect of 4-Methoxy Benzyl Alcohol on the Blood–Brain Barrier after Cerebral Ischemia Reperfusion Injury. Journal of Stroke and Cerebrovascular Diseases. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.01.018